Dr Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE089A01031 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Dr Reddys Labo Dr Reddys Laboratories Ltd. | BSE 1215.70 7.25 (0.60%) | NSE 1218.10 9.20 (0.76%) | Trade | Add

BSE Live

Jan 30, 16:01

1215.70 7.25 (0.60%)

Volume

AVERAGE VOLUME

5-Day

362,381

10-Day

313,456

30-Day

134,545

21,416

Prev. Close

1208.45
Open Price

1198.60

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Jan 30, 15:59

1218.10 9.20 (0.76%)

Volume

AVERAGE VOLUME

5-Day

3,175,903

10-Day

2,729,566

30-Day

1,598,327

1,672,460

Prev. Close

1208.90
Open Price

1200.00

Bid Price (Qty.)
1218.10 (63)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Dr Reddys Laboratories (in Rs. Cr.)	Mar 10	Mar 09	Mar 08	Mar 07	Mar 06
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	4,469.60	4,080.40	3,428.40	3,872.92	2,101.97
Less: Excise/Sevice Tax/Other Levies	74.00	80.90	84.51	89.66	98.71
Revenue From Operations [Net]	4,395.60	3,999.50	3,343.89	3,783.26	2,003.25
Total Operating Revenues	4,395.60	3,999.50	3,343.89	3,783.26	2,003.25
Other Income	254.00	212.20	198.79	242.12	95.97
Total Revenue	4,649.60	4,211.70	3,542.68	4,025.38	2,099.22
EXPENSES
Cost Of Materials Consumed	1,458.00	1,367.60	1,155.06	1,050.02	623.91
Purchase Of Stock-In Trade	245.50	256.40	269.39	152.63	217.19
Operating And Direct Expenses	117.30	105.90	130.35	155.63	74.95
Changes In Inventories Of FG,WIP And Stock-In Trade	-117.30	-64.10	-93.87	-23.23	-36.72
Employee Benefit Expenses	516.40	412.50	366.28	299.04	205.85
Finance Costs	4.10	14.90	6.49	31.84	17.58
Depreciation And Amortisation Expenses	222.40	193.60	161.99	133.50	111.33
Other Expenses	1,099.10	1,175.70	942.18	841.94	608.05
Total Expenses	3,564.80	3,482.20	2,958.58	2,659.53	1,835.46
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	1,084.80	729.50	584.10	1,365.85	263.76
Exceptional Items	0.00	0.00	0.00	0.00	0.00
Profit/Loss Before Tax	1,084.80	729.50	584.10	1,365.85	263.76
Tax Expenses-Continued Operations
Current Tax	256.50	153.80	62.05	173.00	13.83
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-15.40	3.50	29.12	9.00	31.93
Tax For Earlier Years	0.00	0.00	0.00	0.00	0.00
Total Tax Expenses	238.70	168.60	108.88	188.99	52.64
Profit/Loss After Tax And Before ExtraOrdinary Items	846.10	560.90	475.22	1,176.86	211.12
Profit/Loss From Continuing Operations	846.00	560.80	473.67	1,168.66	211.11
Profit/Loss For The Period	846.00	560.80	473.67	1,168.66	211.11
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	50.12	33.30	28.17	69.60	27.53
Diluted EPS (Rs.)	50.12	33.30	28.17	69.60	27.53
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS
Imported Raw Materials	334.20	357.00	231.21	326.16	283.31
Indigenous Raw Materials	766.30	564.20	645.41	561.39	216.17
STORES, SPARES AND LOOSE TOOLS
Imported Stores And Spares	33.20	30.10	21.23	60.23	15.45
Indigenous Stores And Spares	220.20	326.30	180.09	44.41	60.75
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	190.00	105.30	63.06	62.97	38.35
Tax On Dividend	31.60	17.80	10.72	10.70	5.38
Equity Dividend Rate (%)	225.00	125.00	75.00	75.00	100.00